SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-15-005035
Filing Date
2015-01-28
Accepted
2015-01-28 16:05:37
Documents
1
Period of Report
2015-01-26

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 6810
  Complete submission text file 0001104659-15-005035.txt   9228
Mailing Address 699 BOYLSTON ST 11TH FLOOR BOSTON MA 02116
Business Address 699 BOYLSTON ST 11TH FLOOR BOSTON MA 02116 617-600-4164
EPIRUS Biopharmaceuticals, Inc. (Issuer) CIK: 0001135906 (see all company filings)

IRS No.: 043514457 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE FERRY BUILDING, SUITE 255 SAN FRANCISCO CA 94111
Business Address ONE FERRY BUILDING, SUITE 255 SAN FRANCISCO CA 94111 650-234-1200
MONTREUX EQUITY PARTNERS IV LP (Reporting) CIK: 0001423641 (see all company filings)

State of Incorp.: CA
Type: 4 | Act: 34 | File No.: 000-51171 | Film No.: 15554959

Mailing Address ONE FERRY BUILDING, SUITE 255 SAN FRANCISCO CA 94111
Business Address ONE FERRY BUILDING, SUITE 255 SAN FRANCISCO CA 94111 650-234-1200
Montreux Equity Partners V, L.P. (Reporting) CIK: 0001548152 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-51171 | Film No.: 15554958